已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)

医学 退伍军人事务部 肾脏疾病 内科学 2型糖尿病 重症监护医学 糖尿病 肾功能 内分泌学
作者
Lily Agrawal,Nasrin Azad,Gideon Bahn,Ling Ge,Peter D. Reaven,Rodney A. Hayward,Domenic J. Reda,Nicholas Emanuele
出处
期刊:Diabetologia [Springer Science+Business Media]
卷期号:61 (2): 295-299 被引量:65
标识
DOI:10.1007/s00125-017-4473-2
摘要

We conducted an analysis of data collected during the Veterans Affairs Diabetes Trial (VADT) and the follow-up study (VADT-F) to determine whether intensive (INT) compared with standard (STD) glycaemic control during the VADT resulted in better long-term kidney outcomes.VADT randomly assigned 1791 veterans from 20 Veterans Affairs (VA) medical centres who had type 2 diabetes mellitus and a mean HbA1c of 9.4 ± 2% (79.2 mmol/mol) at baseline to receive either INT or STD glucose control for a median of 5.6 years (randomisation December 2000 to May 2003; intervention ending in May 2008). After the trial, participants received routine care through their own physicians within the VA. This is an interim analysis of the VADT-F (June 2008 to December 2013). We collected data using VA and National databases and report renal outcomes based on serum creatinine, eGFR and urine albumin to creatinine ratio (ACR) in 1033 people who provided informed consent to participate in the VADT-F.By the end of the VADT-F, significantly more people who received INT treatment during the VADT maintained an eGFR >60 ml min-1 1.73 m-2 (OR 1.34 [95% CI 1.05, 1.71], p = 0.02). This benefit was most evident in those who were classified as at moderate risk (INT vs STD, RR 1.3, p = 0.03) or high risk (RR 2.3, p = 0.04) of chronic kidney disease on the Kidney Disease Improving Global Outcomes (KDIGO-CKD) at the beginning of VADT. At the end of VADT-F, significantly more people from the INT group improved to a low KDIGO risk category (RR 6.1, p = 0.002). During the VADT-F there were no significant differences between INT and STD for average HbA1c, blood pressure or lipid levels.After just over 11 years of follow-up, there was a 34% greater odds of maintaining an eGFR of >60 ml min-1 1.73 m-2 and of improving the KDIGO category in individuals with type 2 diabetes who had received INT for a median of 5.6 years. VADT clinical trials.gov number: NCT 00032487.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英姑的应助被夜草采纳,获得10
刚刚
1秒前
2秒前
Lee完成签到,获得积分20
2秒前
DW的应助被zzz采纳,获得10
2秒前
3秒前
CipherSage的应助被陈俊瑶采纳,获得10
3秒前
3秒前
4秒前
浮云发布了新的文献求助20
4秒前
PhD_Lee73完成签到,获得积分10
5秒前
5秒前
天线嫣发布了新的文献求助50
5秒前
tomatoGG发布了新的文献求助10
5秒前
6秒前
脑洞疼的应助被冷艳的紫采纳,获得10
6秒前
要减肥的黎云完成签到,获得积分10
6秒前
大哈完成签到,获得积分10
6秒前
今后的应助被晚风采纳,获得10
7秒前
wik完成签到 ,获得积分10
7秒前
康康完成签到,获得积分10
7秒前
曙光发布了新的文献求助10
7秒前
太阳当空照完成签到,获得积分10
9秒前
9秒前
10秒前
万能图书馆的应助被stella采纳,获得10
10秒前
斯文败类的应助被tinner采纳,获得10
11秒前
shelly发布了新的文献求助10
11秒前
11秒前
YHY发布了新的文献求助10
11秒前
11秒前
传奇3的应助被lmplzzp采纳,获得10
12秒前
12秒前
七木完成签到,获得积分10
13秒前
要吃虾饺发布了新的文献求助10
14秒前
14秒前
15秒前
刘壮发布了新的文献求助10
16秒前
背后迎夏完成签到 ,获得积分10
18秒前
YHY完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172444
求助须知:如何正确求助?哪些是违规求助? 9565203
关于积分的说明 21778439
捐赠科研通 7764184
什么是DOI,文献DOI怎么找? 3431343
关于科研通互助平台的介绍 2555224
邀请新用户注册赠送积分活动 2476362